QT
WST icon

Quantamental Technologies’s West Pharmaceutical WST Stock Holding History

Quantamental Technologies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,835
Closed -$1.68M – 686
2022
Q3 		$1.68M Buy
6,835
+5,163
+309% +$1.57M 0.65% 14
2022
Q2 		$506K Buy
1,672
+1,073
+179% +$349K 0.23% 164
2022
Q1 		$246K Buy
+599
New +$234K 0.14% 286
2020
Q4 		– Sell
-1,630
Closed -$448K – 274
2020
Q3 		$448K Buy
+1,630
New +$431K 0.33% 93
2019
Q4 		– Sell
-4,949
Closed -$702K – 1358
2019
Q3 		$702K Buy
4,949
+954
+24% +$131K 0.23% 87
2019
Q2 		$500K Buy
3,995
+1,796
+82% +$212K 0.18% 144
2019
Q1 		$242K Buy
+2,199
New +$229K 0.11% 307

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantamental Technologies's WST Position: Q4 2022 in Review

Quantamental Technologies sold out of West Pharmaceutical (WST) in Q4 2022, closing a stake of 6,835 shares — an estimated $1.68M sold.

Quantamental Technologies first reported a position in WST in Q1 2019 and held it in 7 quarters. The position peaked at $1.68M in Q3 2022. 637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

  • Quantamental Technologies reported no remaining West Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • Quantamental Technologies sold 6,835 West Pharmaceutical shares in Q4 2022, an estimated $1.68M.
  • Quantamental Technologies first reported a position in West Pharmaceutical in Q1 2019 and held it in 7 quarters.
  • Quantamental Technologies's West Pharmaceutical position peaked at $1.68M in Q3 2022.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.